Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) shares reached a new 52-week low during trading on Monday . The ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report) and keeping the price target at ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target of $25.00. Discover the latest stocks recommended by ...

C4 Therapeutics (CCCC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions ...

TECELRA is the first engineered cell therapy for a soli Adaptimmune Therapeutics PLC (ADAP) outlines a path to operating breakeven by 2027, driven by strategic restructuring and promising outcomes ...

SINGAPORE - CytoMed Therapeutics Limited (NASDAQ: GDTC), a biopharmaceutical company specializing in cell-based therapies for cancer treatment, has announced the commencement of a... ByInvesting ...

On Tuesday, H.C. Wainwright adjusted its stock price target for Century Therapeutics (NASDAQ:IPSC) shares, reducing it to $5 from the previous $9, while maintaining a Buy rating ...